ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 102

Xanthine Oxidase Gene Variants and Their Association with Blood Pressure and Incident Hypertension: A Population Based Study

Lieke E.J.M. Scheepers1, Jan A. Staessen2,3, Lutgarde Thijs2, Erika Salvi4, Annelies Boonen5 and Ilja C.W. Arts6, 1Department of Internal Medicine, Division of Rheumatology, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, Netherlands, 2Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology KU Leuven, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium, 3R & D Group VitaK, Maastricht University, Maastricht, Netherlands, 4Department of Health Sciences, University of Milan, Milan, Italy, 5Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 6Department of Epidemiology, CAPHRI School for Public Health and Primary Care, CARIM School for Cardiovascular Diseases, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Gene Expression, gout, hypertension and uric acid

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 8, 2015

Session Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Uric acid (UA) has been associated with blood pressure (BP) and hypertension. During the final stage of purine metabolism, xanthine oxidoreductase (XOR) breaks down hypoxanthine to xanthine, and xanthine to UA, while reactive oxygen species (ROS) are formed. These ROS inactivate the vasodilator nitric oxide. We hypothesize that variants in the XOR gene, responsible for the production of UA, are associated with elevated BP and hypertension. The aim of the present study is to investigate the association of variants in the XOR gene with BP and the development of hypertension.

Methods:

Analyses were conducted in the prospective Flemish FLEMENGHO and European EPOGH study (n=2769). 28 tagging SNPs that are in disequilibrium (r2>0.80) with 387 SNPs covering the entire gene were selected. 24 SNPs remained after exclusion of 4 SNPs not meeting the Hardy-Weinberg equilibrium. Minor allele carriers were determined by using the European HAPMAP population as reference. The minor allele homozygotes and heterozygotes were compared with the major allele homozygotes. BP was measured by trained observers at baseline (1985-2004) and repeatedly during follow-up (1991-2013). The relation between variants of the XOR gene and changes in pulse pressure (PP) and mean arterial pressure (MAP) over time; and incidence of hypertension, were analysed using multivariable mixed models and cox-regression, respectively. Family clusters were modelled as random effect. Analyses were corrected for multiple testing by the Benjamini Hochberg correction, the false discovery rate was set at 0.25.

Results:

Follow-up data for BP were available at 1, 2, or ≥3 occasions in 2769, 1450, and 1035 participants, respectively (median follow-up: 8.79 yrs (IQR: 6.54)). The rise in PP from baseline to the last available measurement was significantly associated with SNP rs11904439, in the crude and confounder adjusted model (adjusted P=<0.01), averaging 8.55 mm Hg (SD 13.6) in minor G allele carriers and 6.33 mm Hg(SD 13.6) in AA homozygotes. The association remained significant after correction for multiple testing. No association with change in MAP was found. Among 2050 participants normotensive at baseline, 753 (36.7%) developed hypertension during follow-up (median follow-up: 10.7 yrs (IQR: 7.3)). Multivariably, two SNPs, rs148756340 and rs11904439, were associated with onset of hypertension. For SNP rs148756340 the minor G allele carriers had a higher risk of hypertension compared to AA homozygotes (adjusted HR: 1.69; 95% CI 1.11 to 2.57, p=0.01). For SNP rs11904439 minor G allele carriers had a higher risk of hypertension compared to AA homozygotes (adjusted HR: 1.33; 95% CI 1.04 to 1.70, p=0.02). For both SNPs the association remained significant after correction for multiple testing.

Conclusion:

Two SNPs, rs11904439 and rs148756340, of the XOR gene were associated with change in PP over time and/or the development of hypertension. This suggests that UA production may be associated with BP and the development of hypertension. Because of the exploratory nature of this study and because it is unknown if the SNP has an effect on the enzyme activity, further investigation is required.


Disclosure: L. E. J. M. Scheepers, None; J. A. Staessen, None; L. Thijs, None; E. Salvi, None; A. Boonen, None; I. C. W. Arts, None.

To cite this abstract in AMA style:

Scheepers LEJM, Staessen JA, Thijs L, Salvi E, Boonen A, Arts ICW. Xanthine Oxidase Gene Variants and Their Association with Blood Pressure and Incident Hypertension: A Population Based Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/xanthine-oxidase-gene-variants-and-their-association-with-blood-pressure-and-incident-hypertension-a-population-based-study/. Accessed March 1, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/xanthine-oxidase-gene-variants-and-their-association-with-blood-pressure-and-incident-hypertension-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.